Blood Group (BG) Prevalence In End-Stage (ES) Renal Disease (RD): Relationship To Ristocetin Willebrand Factor (VIII: RWF) And Platelet Survival (PS) [PDF]
Victor J. Torres +5 more
openalex +1 more source
Proceedings: Platelet aggregation with ristocetin. [PDF]
J Hughes +3 more
openaire +3 more sources
The relationship of the properties of antihemophilic factor (factor VIII) that support ristocetin-induced platelet agglutination (factor VIIIR:RC) and platelet retention by glass beads as demonstrated by a monoclonal antibody [PDF]
K Ogata, H Saito, Ratnoff Od
openalex +1 more source
Management of von Willebrand disease type 3 during pregnancy - 2 cases reports. [PDF]
BACKGROUND: von Willebrand disease type 3, is an extremely rare condition. It can be severe and potentially life-threatening, particularly in pregnant women during labor and subsequently during early puerperium.
Azevedo, S. +3 more
core
Ristocetins, Inhibitors of Cell Wall Synthesis in Staphylococcus aureus
Charles H. Wallas, J L Strominger
openalex +1 more source
Promotion of binding of von Willebrand factor to platelet glycoprotein Ib by dimers of ristocetin [PDF]
Marc Hoylaerts +4 more
openalex +1 more source
Use of the collagen‐binding assay for von Willebrand factor in the analysis of type 2M von Willebrand disease: a comparison with the ristocetin cofactor assay [PDF]
Anne Riddell +5 more
openalex +1 more source
Synthesis and antibacterial evaluation of some teicoplanin pseudoaglycon derivatives containing alkyl- and arylthiosubstituted maleimides [PDF]
Batta, Gyula +12 more
core +1 more source
Plasma glycocalicin as a source of GPIbα in the von Willebrand factor ristocetin cofactor ELISA [PDF]
Inge Pareyn +6 more
openalex +1 more source

